Hepatocarcinoma Clinical Trial
— 3D-HAPPIOfficial title:
Multicentric Study Determining the Benefit of the Use of 3D Models and Tools in Hepatectomy Planning for Hepatocarcinomas
Verified date | February 2021 |
Source | IHU Strasbourg |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The aim of this study is to assess the benefit of 3D models in the planning of hepatic resection by comparing the changes in the surgical plan based on the analysis of conventional preoperative images (CT-scan and MRI), compared to the surgical plan based on the analysis of 3D reconstruction.
Status | Completed |
Enrollment | 136 |
Est. completion date | October 16, 2020 |
Est. primary completion date | October 16, 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Patient with a hepatocarcinoma, eligible for surgical resection - Patient over 18 years old - Patient able to understand the study and provide written informed consent - Patient affiliated to the French social security system. Exclusion Criteria: - Patient with other liver tumours - Patient whose general condition is not suitable for study participation (WHO = 3) - Patient with a condition preventing its participation to study procedures, according to investigator's judgment - Patient with contraindications to injected CT-scan or MRI: allergic reaction to contrast agents, kidney failure, pacemaker, claustrophobia - Pregnancy or breastfeeding - Patient in exclusion period (determined by a previous study or in progress) - Patient in custody - Patient under guardianship. |
Country | Name | City | State |
---|---|---|---|
France | Service de Chirurgie Digestive - Hôpital Beaujon | Clichy | |
France | Hôpital Henri Mondor - Service de Chirurgie Digestive et Hépatobiliaire - | Créteil | |
France | Service de Chirurgie Digestive et Transplantation - Hôpital Claude Huriez | Lille | |
France | Service de Chirurgie Digestive et Transplantation Hépatique - Hôpital universitaire de la Croix-Rousse | Lyon | |
France | Service de Chirurgie Digestive - CH Emile Muller | Mulhouse | |
France | Chirurgie Viscérale et Digestive - Polyclinique de Gentilly | Nancy | |
France | Chirurgie Digestive, Hépato-bilio-pancréatique et Transplantation - La Pitié Sâlpêtrière | Paris | |
France | Service de Chirurgie Digestive - CHU Robert Debré | Reims | |
France | Service de Chirurgie Digestive Hôpital Charles Nicolle - CHU Rouen | Rouen | |
France | Institut de Chirurgie Viscérale - Clinique de l'Orangerie | Strasbourg | |
France | Service de Chirurgie Digestive et Endocrinienne - Nouvel Hôpital Civil | Strasbourg | |
France | Centre Hépato-Biliaire - Hôpital Paul Brousse | Villejuif |
Lead Sponsor | Collaborator |
---|---|
IHU Strasbourg |
France,
Couinaud C. [Errors in the topographic diagnosis of liver diseases]. Ann Chir. 2002 Jun;127(6):418-30. Review. French. — View Citation
Gauss T, Merckx P, Brasher C, Kavafyan J, Le Bihan E, Aussilhou B, Belghiti J, Mantz J. Deviation from a preoperative surgical and anaesthetic care plan is associated with increased risk of adverse intraoperative events in major abdominal surgery. Langenbecks Arch Surg. 2013 Feb;398(2):277-85. doi: 10.1007/s00423-012-1028-3. Epub 2012 Nov 13. — View Citation
Mutter D, Dallemagne B, Bailey Ch, Soler L, Marescaux J. 3D virtual reality and selective vascular control for laparoscopic left hepatic lobectomy. Surg Endosc. 2009 Feb;23(2):432-5. doi: 10.1007/s00464-008-9931-y. Epub 2008 Apr 29. — View Citation
Mutter D, Soler L, Marescaux J. Recent advances in liver imaging. Expert Rev Gastroenterol Hepatol. 2010 Oct;4(5):613-21. doi: 10.1586/egh.10.57. Review. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Comparison of the intra-operative modifications rates | Modifications in the surgical planning compared to the plan based on the analysis of standard preoperative images (CT-scan and MRI) and the plan based on the 3D model analysis: changes in surgical resection type (by specifying the surgical act: tumorectomy, segmentectomy, bi-segmentectomy or lobectomy…) or no surgery. | At time of surgery | |
Secondary | Comparison of tumor(s) location | Comparison of tumor(s) location based on 3D model and standard preoperative images analysis. | At time of surgery | |
Secondary | Comparison of vascular network anatomy | Comparison of vascular network anatomy based on 3D model and standard preoperative images analysis. | At time of surgery | |
Secondary | Choice of surgical plan | Surgery done according to a) surgical plan based on standard preoperative images analysis, b) surgical plan based on 3D model analysis or c) alternative approach (by specifying the surgical act: tumorectomy, segmentectomy, bi-segmentectomy or lobectomy….) | At time of surgery | |
Secondary | Modification of the initial surgical plan, if applicable | Description of perioperative events having modified the initial surgical plan. | At time of surgery | |
Secondary | Comparison of resection merges | Comparison of expected resection merges based on standard preoperative images and 3D model analysis and actual resection merge in the operating room. | At time of surgery | |
Secondary | Comparison of resection volumes | Comparison of expected resection volumes based on standard preoperative images and 3D model analysis and actual resection volume in the operating room. | At time of surgery | |
Secondary | Comparison of surgical merge size | Comparison of surgical merge size (mm) based on 3D model and standard preoperative images analysis. | At time of surgery | |
Secondary | Morbidity | Morbidity specific to the procedure. | At time of surgery and 3 months after surgery | |
Secondary | Mortality | Mortality specific to the procedure. | At time of surgery and 3 months after surgery | |
Secondary | Preoperative images independent analysis | Analysis of preoperative images (CT-scan/MRI and 3D model) by a senior team on one hand, and a junior team (surgeons + radiologists) on the other hand. | 3 years |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT06041490 -
Adjuvant Therapy for High-risk Hepatocellular Carcinoma Post Liver Transplantation
|
Phase 2 | |
Terminated |
NCT03956940 -
Analysis of cfDNA in Patients With Hepatocarcinoma and Treated by Sorafenib or Regorafenib
|
N/A | |
Recruiting |
NCT03755739 -
Trans-Artery/Intra-Tumor Infusion of Checkpoint Inhibitors Plus Chemodrug for Immunotherapy of Advanced Solid Tumors
|
Phase 2/Phase 3 | |
Recruiting |
NCT06028724 -
A Study on the Prevalence of Clinically Useful Mutations in Solid Tumor Characterized by Next Generation Sequencing Methods on Liquid Biopsy Analysis (POPCORN)
|
||
Not yet recruiting |
NCT03718078 -
Robotic Endomicroscopy to Better Define Resection Strategies Applied to Hepatic Surgery
|
N/A | |
Recruiting |
NCT05794048 -
METabolic PROFILE of Hepatocarcinoma and Pancreatic Tumors
|
N/A | |
Recruiting |
NCT04435977 -
Efficacy and Safety of Cabozantinib in Patients With Hepatocellular Carcinoma
|
Phase 2 | |
Completed |
NCT04811898 -
A Dose Escalation Study of LNA-i-Mir-221 for Cancer Treatment
|
Phase 1 | |
Recruiting |
NCT05311319 -
HAIC Combined With Anlotinib and TQB2450 as Adjuvant Therapy in HCC Patients With High Risk of Recurrence After Resection
|
Phase 2 | |
Completed |
NCT05464706 -
Study on the Quality of Life (QoL) After Liver Surgery
|
N/A | |
Completed |
NCT01411579 -
Use of DwI-MR to Predict Chemotherapy Response of Liver Metastases and Hepatocarcinoma
|
N/A | |
Completed |
NCT02519075 -
11C-Choline PET/CT and DWI MRI for Response Assessment of HCC Candidate to TARE
|
||
Recruiting |
NCT03356236 -
Huaier Granule for Prevention of Recurrence and Metastasis of Hepatocarcinoma Following Local Ablation
|